Search...

⌘K

Try AI Medical Scribe

Save 2+ hours daily with instant clinal dicumentation.

Start Free Trial

Ranson's Criteria for Pancreatitis Mortality

Ranson’s Criteria (Pancreatitis)

ssesses the severity and prognosis of acute pancreatitis

Ranson's Criteria for Pancreatitis Mortality

Ranson’s Criteria (Pancreatitis)

ssesses the severity and prognosis of acute pancreatitis

At Admission
Age > 55 years
WBC > 16,000 cells/mm³
Glucose > 200 mg/dL (>11.1 mmol/L)
LDH > 350 IU/L
AST > 250 IU/L
48 Hours Into Admission
Hct drop > 10% from admission
BUN increase > 5 mg/dL (>1.79 mmol/L) from admission
Ca < 8 mg/dL (< 2 mmol/L)
Arterial pO₂ < 60 mmHg
Base deficit > 4 mEq/L
Fluid sequestration > 6 L
Answer all questions to see your score
0/11 answered · select options to update

Instructions

To use this tool, record specific clinical and laboratory values at admission and again at 48 hours. At admission, age, white blood cell count, blood glucose, AST, and LDH are assessed. At 48 hours, additional factors such as hematocrit fall, BUN rise, calcium, arterial oxygen, fluid sequestration, and base deficit are measured. Each positive finding is assigned one point. The total score is then calculated and interpreted to predict the risk of mortality. Always ensure values are accurate and time-specific when applying this tool.

Overview
When to use
Why use
Evidences

Interpretation

Score

Severity

0–2

Mild

3–4

Moderate

5–6

Severe

≥7

Very Severe

Ranson’s Criteria is an 11‑parameter score assessed at admission and at 48 hours to predict acute pancreatitis severity and mortality; although historically important, it is slower to complete and has variable performance compared with newer tools (e.g., BISAP, APACHE II) and the Revised Atlanta classification, and is best used alongside early clinical assessment and serial labs.
https://www.ncbi.nlm.nih.gov/books/NBK482345/

Parameters at admission: age >55 years, WBC >16,000/mm3, glucose >200 mg/dL, LDH >350 IU/L, AST >250 IU/L; at 48 hours: hematocrit fall >10 percentage points, BUN rise >5 mg/dL, Ca <8 mg/dL, PaO2 <60 mmHg, base deficit >4 mEq/L, fluid sequestration >6 L.
https://pmc.ncbi.nlm.nih.gov/articles/PMC2702891/

Reported sensitivities for severe pancreatitis prediction range from ~40% to 90% across cohorts, reflecting heterogeneity in etiology and care; APACHE II often shows similar or better discrimination and has the advantage of serial scoring.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3800571/

Multi‑tool comparisons show Ranson and APACHE II among higher‑performing multifactorial scores, while simpler early scores like BISAP perform competitively for early risk stratification and are easier to use within the first 24 hours.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9727576/

Consider Ranson for retrospective risk stratification and as a complement to early tools (e.g., BISAP at 24 h) and dynamic scores (APACHE II), while prioritizing serial BUN, hematocrit, and organ failure assessment for ongoing management decisions.
https://www.ncbi.nlm.nih.gov/books/NBK482468/

Overview
When to use
Why use
Evidences

The Ranson’s Criteria is one of the earliest and most widely recognized scoring systems developed to predict the severity and outcomes of acute pancreatitis. Introduced by Dr. John Ranson in the 1970s, it uses a combination of clinical and biochemical markers collected at admission and within 48 hours of hospitalization. The system includes 11 parameters: five at the time of admission and six within the first 48 hours. Each abnormal finding contributes one point toward the overall score.

The score correlates strongly with the risk of complications and mortality. For example, lower scores (0–2) generally predict mild disease with low mortality, while higher scores (≥6) are associated with severe pancreatitis and a significantly increased risk of death. Although modern scoring systems and imaging methods have supplemented it, Ranson’s Criteria remains a reliable, cost-effective, and widely taught method, particularly in resource-limited settings.

It is primarily used for prognostication and management planning rather than immediate diagnosis. Clinicians apply it to anticipate intensive care needs, guide monitoring frequency, and counsel patients and families regarding expected outcomes. While it is less convenient than simpler tools (like BISAP or APACHE II) because of the 48-hour delay, it continues to hold value in both clinical practice and medical education.

Overview
When to use
Why use
Evidences

Interpretation

Score

Severity

0–2

Mild

3–4

Moderate

5–6

Severe

≥7

Very Severe

Ranson’s Criteria is an 11‑parameter score assessed at admission and at 48 hours to predict acute pancreatitis severity and mortality; although historically important, it is slower to complete and has variable performance compared with newer tools (e.g., BISAP, APACHE II) and the Revised Atlanta classification, and is best used alongside early clinical assessment and serial labs.
https://www.ncbi.nlm.nih.gov/books/NBK482345/

Parameters at admission: age >55 years, WBC >16,000/mm3, glucose >200 mg/dL, LDH >350 IU/L, AST >250 IU/L; at 48 hours: hematocrit fall >10 percentage points, BUN rise >5 mg/dL, Ca <8 mg/dL, PaO2 <60 mmHg, base deficit >4 mEq/L, fluid sequestration >6 L.
https://pmc.ncbi.nlm.nih.gov/articles/PMC2702891/

Reported sensitivities for severe pancreatitis prediction range from ~40% to 90% across cohorts, reflecting heterogeneity in etiology and care; APACHE II often shows similar or better discrimination and has the advantage of serial scoring.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3800571/

Multi‑tool comparisons show Ranson and APACHE II among higher‑performing multifactorial scores, while simpler early scores like BISAP perform competitively for early risk stratification and are easier to use within the first 24 hours.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9727576/

Consider Ranson for retrospective risk stratification and as a complement to early tools (e.g., BISAP at 24 h) and dynamic scores (APACHE II), while prioritizing serial BUN, hematocrit, and organ failure assessment for ongoing management decisions.
https://www.ncbi.nlm.nih.gov/books/NBK482468/

Frequently Asked Questions

Features and Services FAQs

Discover the full range of features and services we offer and how to use them.

What is the main purpose of Ranson’s Criteria?+
Why are values collected at both admission and 48 hours?+
Is Ranson’s Criteria useful for both alcoholic and non-alcoholic pancreatitis?+
How does it compare to other scoring systems like BISAP or APACHE II?+
Can Ranson’s Criteria guide treatment decisions directly?+
What if some lab values are unavailable at the right time?+

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.

Model for End-Stage Liver Disease (Combined MELD)